Combined application of block and modulation factors to reduce the volume of the low dose area in helical tomotherapy plans for lung cancer

结合使用阻挡因子和调制因子来减少肺癌螺旋断层放射治疗计划中低剂量区域的体积

阅读:2

Abstract

BACKGROUND: The helical tomotherapy (HT) system can expose more normal lung tissue to low radiation doses, resulting in extensive low-dose distribution in both lungs which may induce radiation pneumonitis (RP). PURPOSE: This study aims to optimize dosimetric parameters and identify a clinically feasible treatment plan by analyzing the impact of different block settings and modulation factor (MF) combinations on HT plans for lung cancer to reduce the low-dose exposure volumes in normal lung tissue. METHODS: We retrospectively reviewed 14 lung cancer patients who received radiotherapy. These cases were optimized using different modulation factors (MFs: 3, 4, 5) and block techniques (Unblocked, Directional, Complete). The impact of MF and block combinations on reducing low-dose bath (e.g., V5, V10) in lung tissue was evaluated by analyzing dose distribution maps, dose-volume histograms (DVH), homogeneity index (HI), conformity index (CI), and treatment time for each optimized HT plan combination. RESULTS: Block settings and higher MF exerted minimal influence on the average dose to the target volume. With stricter block constraints and higher MF, HI increased (range: 17.39%-27.54%) and CI decreased (range: 2.76%-17.43%); although both indices showed slight deterioration, they remained within acceptable clinical limits. Treatment time increased substantially (range: 15.77%-131.58%). The block technique significantly reduced V5 in the bilateral lungs and the contralateral (healthy) lung, with less impact on the ipsilateral (affected) lung. The combination of block and high MF effectively reduced V5. CONCLUSIONS: To balance target volume coverage (high dose), dose distribution uniformity, and treatment duration while reducing low-dose irradiation to normal lung tissue, we recommend implementing Directional block with an MF range of 3-4 to optimize the HT plan for patients with unilateral lung cancer.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。